Proteomic Studies of Primary Acute Myeloid Leukemia Cells Derived from Patients Before and during Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid and Valproic Acid

SIMPLE SUMMARY: Acute myeloid leukemia (AML) is an aggressive hematological malignancy, and the only possibility of cure is intensive antileukemic treatment. Such treatment is only possible for relatively young and fit patients, but there is a large subset of elderly/unfit patients above 65–70 years...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernandez-Valladares, Maria, Wangen, Rebecca, Aasebø, Elise, Reikvam, Håkon, Berven, Frode S., Selheim, Frode, Bruserud, Øystein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125016/
https://www.ncbi.nlm.nih.gov/pubmed/33946813
http://dx.doi.org/10.3390/cancers13092143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125016/
https://www.ncbi.nlm.nih.gov/pubmed/33946813
http://dx.doi.org/10.3390/cancers13092143

Ejemplares similares